Back to search
FDAFDA · Food and drugs·Recall number D-0146-2020

Leucovorin Calcium Injection, USP 500 mg*/50 mL (10 mg/mL) 50 mL Single-Dose Vial NDC 50742-464-50 Rx Only Ingenus Pharmaceuticals, LLC. Orlando, FL 32839

Published October 23, 2019 · Recall initiated: October 9, 2019

Summary

FDA records drug Class II recall D-0146-2020, published October 23, 2019 and initiated October 9, 2019. Recalling firm: Ingenus Pharmaceuticals Llc; Status: Terminated; Reported quantity: 16485 vials; Lot: Lot#: 18048, 18049 Exp. 04/2020; 18050 Exp 05/2020; 19036 Exp 12/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Crystallization: Presence of particulate matter identified as API crystallization

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Ingenus Pharmaceuticals Llc
Distributor
U.S.A. Nationwide
Lot
Lot#: 18048, 18049 Exp. 04/2020; 18050 Exp 05/2020; 19036 Exp 12/2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Leucovorin Calcium Injection, USP 500 mg*/50 mL (10 mg/mL) 50 mL Single-Dose Vial NDC 50742-464-50 Rx Only Ingenus Pharmaceuticals, LLC. Orlando, FL 32839 recalled?

Yes. FDA published recall D-0146-2020 on October 23, 2019. Reported hazard: Crystallization: Presence of particulate matter identified as API crystallization

What should I do if I have this product?

Voluntary: Firm initiated · Letter